Form 4: CATX Chief Accounting Officer Buys 11,000 Shares

Perspective Therapeutics' Chief Accounting Officer, Jonathan Hunt, acquired 11,000 shares of common stock, increasing his beneficial ownership.

Summary

• Jonathan Robert Hunt, Chief Accounting Officer of Perspective Therapeutics, Inc. (CATX), acquired 11,000 shares of common stock.
• The transaction occurred on November 13, 2025, at a weighted average price of $2.0268 per share.
• Shares were purchased in multiple transactions ranging from $2.0235 to $2.0300.
• Following this acquisition, Mr. Hunt beneficially owns 59,800 shares of Perspective Therapeutics, Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a significant insider purchase by a key executive, which typically signals confidence in the company's future prospects and valuation.

Positives

• Insider buying by a key executive, the Chief Accounting Officer, signals confidence in the company's future prospects.
• The acquisition of 11,000 shares increases the executive's direct stake and aligns his interests more closely with shareholders.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

Insider purchases are often viewed by the market as a positive indicator, suggesting that those with intimate knowledge of the company believe its stock is undervalued or that significant positive developments are anticipated. This transaction by a Chief Accounting Officer, who has deep insight into the company's financial health, can be particularly impactful.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive sign, potentially increasing confidence in the company's stock.
• The increased beneficial ownership by a key executive aligns management's interests more closely with those of other shareholders.

Key Dates

Recommendation

The acquisition of shares by a Chief Accounting Officer, who possesses detailed knowledge of the company's financial position, is a strong indicator of internal confidence. Such insider buying often precedes positive company performance or reflects a belief that the stock is currently undervalued, making it a compelling 'buy' signal for investors.

Keywords

Perspective Therapeutics, CATX, Insider Buying, Stock Acquisition, Chief Accounting Officer, Jonathan Hunt, SEC Form 4, Beneficial Ownership